Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Willem W OverwijkJohn B A G Haanen

Abstract

The promising, but modest, clinical results of many human cancer vaccines indicate a need for vaccine adjuvants that can increase both the quantity and the quality of vaccine-induced, tumor-specific T cells. In this study we tested the immunological and antitumor effects of the proinflammatory cytokine, IL-23, in gp100 peptide vaccine therapy of established murine melanoma. Neither systemic nor local IL-23 alone had any impact on tumor growth or tumor-specific T cell numbers. Upon specific vaccination, however, systemic IL-23 greatly increased the relative and absolute numbers of vaccine-induced CD8(+) T cells and enhanced their effector function at the tumor site. Although IL-23 specifically increased IFN-gamma production by tumor-specific T cells, IFN-gamma itself was not a primary mediator of the vaccine adjuvant effect. The IL-23-induced antitumor effect and accompanying reversible weight loss were both partially mediated by TNF-alpha. In contrast, local expression of IL-23 at the tumor site maintained antitumor activity in the absence of weight loss. Under these conditions, it was also clear that enhanced effector function of vaccine-induced CD8(+) T cells, rather than increased T cell number, is a primary mechanism underl...Continue Reading

References

Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·K Staveley-O'CarrollH Levitsky
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·D M Pardoll
Apr 5, 2001·Trends in Immunology·W W Overwijk, N P Restifo
Jun 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M T WiekowskiS A Lira
Aug 11, 2001·Current Opinion in Immunology·D H Barouch, N L Letvin
Sep 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·K E de VisserA M Kruisbeek
Oct 13, 2001·Cancer·R Kurzrock
Mar 28, 2002·Human Gene Therapy·Takafumi NakamuraHirofumi Hamada
Apr 26, 2002·Current Opinion in Immunology·Roman A Tuma, Eric G Pamer
May 11, 2002·Nature Reviews. Immunology·Drew M Pardoll
May 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Maria Laura BelladonnaPaolo Puccetti
May 23, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christi ParhamKevin W Moore
Nov 26, 2002·Immunological Reviews·Pierre G CoulieThierry Boon
Nov 26, 2002·Immunological Reviews·Glenn Dranoff
Dec 10, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Javier ValenzuelaMatthew Mescher
Mar 14, 2003·Current Opinion in Immunology·Pierre G Coulie, Pierre van der Bruggen
May 22, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tamara KoppGeorg Stingl
May 27, 2003·International Journal of Cancer. Journal International Du Cancer·Yan-Qing WangMasatoshi Tagawa
Jun 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Amy C PetersonThomas F Gajewski
Jul 9, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Chia-Hui LoMi-Hua Tao
Aug 20, 2003·The Journal of Experimental Medicine·Willem W OverwijkNicholas P Restifo
Oct 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jiu JiangHao Shen
Dec 10, 2003·The Journal of Experimental Medicine·Craig A MurphyDaniel J Cua
Dec 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sang-Jun HaYoung-Chul Sung
Mar 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Stefan BauerChristoph Renner
Mar 10, 2004·The Journal of Experimental Medicine·Cory L AhonenRoss M Kedl
Apr 9, 2004·The New England Journal of Medicine·Steven A Rosenberg
May 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·David SchramaJürgen C Becker
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Sep 24, 2004·The Journal of Experimental Medicine·Mary Jo TurkAlan N Houghton

❮ Previous
Next ❯

Citations

Jun 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Teruo KaigaHideaki Tahara
Oct 27, 2007·Expert Opinion on Biological Therapy·Jonathan M WeissRobert H Wiltrout
Oct 13, 2007·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Masanori Matsui
Jul 16, 2008·The Journal of Dermatological Treatment·Adam AsarchAlice B Gottlieb
Aug 30, 2008·Expert Opinion on Drug Delivery·Yin Hwa Lai, Chong Wang
Jun 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew G SikoraWillem W Overwijk
Apr 21, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michele W L TengMark J Smyth
May 4, 2007·Journal of Translational Medicine·Francesco M Marincola
Nov 19, 2009·Cancer Immunology, Immunotherapy : CII·Mohamed Labib Salem, David J Cole
Jan 18, 2013·Blood·Pawel Muranski, Nicholas P Restifo
Jun 27, 2013·Oncoimmunology·Andreas A Hombach, Hinrich Abken
Jun 5, 2007·Expert Review of Vaccines·Clint S SchmidtNadeem A Sheikh
Mar 21, 2008·Blood·Pawel MuranskiNicholas P Restifo
Jul 9, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Paula R KroeningRobert Vassallo
Feb 26, 2008·Expert Opinion on Biological Therapy·Ena WangFrancesco M Marincola
Mar 27, 2018·International Journal of Cancer. Journal International Du Cancer·Manouchehr TeymouriAmirhosein Sahebkar
Feb 6, 2020·Nature Biotechnology·Xingcong MaYang Xu
Feb 9, 2007·The New England Journal of Medicine·Gerald G KruegerUNKNOWN CNTO 1275 Psoriasis Study Group
Mar 26, 2010·Nature Reviews. Immunology·Weiping Zou, Nicholas P Restifo
Feb 10, 2011·Carcinogenesis·Cailin Moira WilkeWeiping Zou
Nov 8, 2012·Future Oncology·Jessica A CintoloBrian J Czerniecki
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michele Del VecchioAndrea Anichini
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenichi KoyamaFumitake Gejyo
Apr 24, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jacob S BowersChrystal M Paulos
Sep 2, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nicola Giuliani, Irma Airoldi
Mar 15, 2021·Trends in Immunology·Jee Hye KangArabella Young
Jun 7, 2011·Surgical Oncology Clinics of North America·Richard L White, Asim Amin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.